ONCO Onconetix, Inc.
Price Chart
Executive Summary
Onconetix, Inc. announced the resignation of directors Andrew Oakley and Thomas Meier, the appointment of Sammy Dorf as Chairman of the Board with $20,000 annual compensation, and the election of Josh Epstein to the Board and its committees. The changes reflect a board refreshment with no disclosed disagreements or operational issues.
Actionable Insight
Monitor upcoming proxy filings for full director compensation details and any further governance changes. The addition of Epstein with M&A and capital markets expertise may signal strategic development plans, though no immediate financial impact is expected.
Key Facts
- Andrew Oakley and Thomas Meier resigned from the Board of Directors effective April 20, 2026, with no disagreements reported.
- Sammy Dorf was appointed Chairman of the Board effective April 23, 2026, and will receive $20,000 per year in compensation.
- Josh Epstein was elected to the Board and named chair of the Nominating and Corporate Governance Committee, bringing extensive cross-industry executive and legal experience.
- Epstein's compensation will be consistent with other non-employee directors.
- Oakley also stepped down as Chairman and from the Audit, Compensation, and Nominating Committees; Meier resigned from the Compensation Committee.
Financial Impact
Minimal; $20,000 annual increase in director compensation
Risk Factors
- Potential loss of institutional investor confidence if board stability is perceived as weak
- Integration risk of new directors into key committees
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-047577 |
| Document: 0001213900-26-047577-index-headers.html | 0001213900-26-047577 |
| Document: 0001213900-26-047577-index.html | 0001213900-26-047577 |
| Document: 0001213900-26-047577.txt | 0001213900-26-047577 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 19, 2026
21d ago
|
Press Release
| $1.18 $1.20 | ▼ −1.70% | ▲ +0.54% | $0.9469 (+19.75%) |
|
May 13, 2026
27d ago
|
Press Release
| $3.87 $1.10 | ▼ −71.58% | ▼ −71.44% | $0.9469 (−75.53%) |
|
May 8, 2026
4w ago
|
EFFECT
| $3.80 $3.74 | ▲ +1.58% | ▲ +1.79% | $0.9469 (+75.08%) |
|
May 7, 2026
4w ago
|
S-1/A
| $4.04 $3.90 | ▼ −3.47% | ▼ −5.76% | $0.9469 (−76.56%) |
|
Apr 24, 2026
6w ago
|
8-K
| $7.42 $6.47 | ▼ −12.83% | ▼ −13.23% | $0.9469 (−87.24%) |
|
Apr 16, 2026
7w ago
|
3
| $7.60 $6.66 | ▼ −12.32% | ▼ −13.30% | $0.9469 (−87.54%) |
|
Apr 9, 2026
8w ago
|
PRESS-RELEASE / 425
| $12.20 $7.60 | ▼ −37.70% | ▼ −40.89% | $0.9469 (−92.24%) |
|
Apr 2, 2026
9w ago
|
PRESS-RELEASE / 425
| $15.20 $10.90 | ▼ −28.29% | ▼ −31.91% | $0.9469 (−93.77%) |
|
Mar 31, 2026
10w ago
|
425
| $14.90 $11.30 | ▼ −24.16% | ▼ −28.11% | $0.9469 (−93.64%) |
|
Mar 31, 2026
10w ago
|
Press Release
| $14.90 $11.30 | ▼ −24.16% | ▼ −28.11% | $0.9469 (−93.64%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access